Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06618742

Focal Cryoballoon Ablation for Malignant Dysphagia

Led by Laura Boer · Updated on 2024-10-01

20

Participants Needed

1

Research Sites

79 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Rationale: Dysphagia is commonly encountered in patients with esophageal carcinoma who are no candidates for treatment with curative intent. It often has a considerable impact on quality of life and can cause malnourishment. Current palliative treatments mainly include esophageal stenting and radiotherapy, but these can be associated with substantial drawbacks such as a high rate of adverse events, fatigue or an untimely/ temporary symptom improvement. Recent studies showed promising results for the use of spray cryotherapy as palliation for dysphagia. Moreover, there are suggestions that cryotherapy has a positive effect on the host's anti-tumor response. However, no data exists on the feasibility, efficacy and safety for cryoballoon therapy in the esophagus. Secondly, cryo-immunologic data in patients with EC is lacking. Objective: 1. To evaluate the feasibility of cryoballoon ablation in patients with esophageal carcinoma and symptoms of dysphagia. Additionally, efficacy and safety will be assessed. 2. To evaluate the effect of cryoballoon ablation on host's anti-tumor response. Study design: Pilot study, Multi-center Prospective Uncontrolled Intervention Study Study population: Adult patients (≥18 years) with dysphagia due to incurable esophageal carcinoma Intervention (if applicable): Focal cryoballoon ablation of visible tumor during an upper endoscopy. Cryoballoon ablation will be performed for two cycles of 12 seconds. In total, patients will undergo 3 treatment sessions (range 1-3) with an interval of 1-3 weeks based onthe severity of symptoms reported by the patient. Main study parameters/endpoints: * \- Feasibility of cryoballoon ablation defined as technical success of the procedure * Safety based on incidence of procedure-related serious adverse events * Efficacy defined as success rates two weeks after the last cryoablation treatment based on patient reported symptom improvement, and objective evaluation of the esophageal lumen that is free from tumor * Host's anti-tumor response after cryoballoon ablation based on sequential esophageal tumor biopsies and peripheral blood samples

CONDITIONS

Official Title

Focal Cryoballoon Ablation for Malignant Dysphagia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age greater than 18 years at time of consent
  • Histopathologically-confirmed esophageal or gastroesophageal cancer
  • Patients receiving palliative care with or without systemic chemotherapy
  • Dysphagia score of 2 or higher (able to swallow only semi-solids)
  • Signed written informed consent
Not Eligible

You will not qualify if you...

  • Dysphagia caused by reasons other than esophageal cancer
  • Unable to pass the ultraslim endoscope
  • Severe medical conditions preventing endoscopy
  • Uncorrected blood clotting problems
  • Prior distal esophagectomy surgery
  • Previous esophageal varices
  • Expected survival less than 6 weeks
  • Prior radiotherapy for esophageal cancer
  • T4b stage esophageal cancer
  • Incapacitated individuals
  • Pregnant or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UMCU

Utrecht, Netherlands

Actively Recruiting

Loading map...

Research Team

L

Laura S Boer, Degree of medicine

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Focal Cryoballoon Ablation for Malignant Dysphagia | DecenTrialz